Why Guardian Pharmacy Services, Inc.’s (GRDN) Stock Is Down 5.79%
As of Tuesday, August 11, Guardian Pharmacy Services, Inc.’s GRDN share price has dipped by 5.79%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Stock Evaluator: Guardian Pharmacy Services, Inc. (GRDN)
Guardian Pharmacy Services, Inc. GRDN
$37.29
-0.19
-0.51%
August 21, 2026 12:14:00 PM
EST
Volume: 63,248
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Commentary & Analysis
Why Guardian Pharmacy Services, Inc.’s (GRDN) Stock Is Up 14.82%
As of Friday, August 07, Guardian Pharmacy Services, Inc.’s GRDN share price has surged by 14.82%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Guardian Pharmacy Services, Inc.’s (GRDN) Stock Is Up 18.71%
As of Friday, August 07, Guardian Pharmacy Services, Inc.’s GRDN share price has surged by 18.71%, which has investors questioning if this is right time to sell.Tudor Pop
Is Guardian Pharmacy Services, Inc. (GRDN) Overvalued?
We dive into why Guardian Pharmacy Services, Inc. (GRDN) could be considered overvalued on 2026-08-04, based on AAII’s Value Score and Grade.Jenna Brashear
Which Is a Better Investment, Guardian Pharmacy Services, Inc. or NeoGenomics, Inc. Stock?
Learn more about whether Guardian Pharmacy Services, Inc. or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Financial Summary
| Share Statistics | GRDN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,374.1 | $1,982.5 | 56% |
|
| Shares Out (Mil) | 63.8 | 77.7 | 53% |
|
| Institutional Ownership | 74.3% | 86.1% | 45% |
|
| Float (Mil) | 32.0 | 52.1 | 37% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 445 | 637 | 56% |
|
| Price Change (52-week) |
47.6% | 79.7% | 78% |
|
| Growth | GRDN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.5% | 10.9% | 72% |
|
| Net Income (5yr) | 19.8% | (1.6%) | 73% |
|
| EPS (5yr) | na | 0.3% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | $0.315 | $1.303 | $1.430 | |
| Month Ago EPS | $0.302 | $1.260 | $1.358 | |
| # Rev Up | 2 | 1 | 3 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.302 | $1.260 | $1.358 | |
| Year/Year Chg | (8.2%) | 67.5% | 102.2% | |
| Financials | GRDN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,463 | $1,504 | 56% |
|
| Net Income (TTM) (Mil) | $66 | $28 | 57% |
|
| EPS (TTM) | $1.046 | $0.200 | 61% |
|
| Operating Cash Flow (TTM) (Mil) | $99 | $162 | 52% |
|
| Net Cash Flow (TTM) (Mil) | $71 | $9 | 74% |
|
| Long-Term Debt (Q1) (Mil) | $32 | $338 | 35% |
|
| Enterprise Value (Q1) (Mil) | $2,405 | $2,416 | 51% |
|
| Valuation | GRDN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.66 | 2.79 | 89% |
|
| P/E | 36.2 | 25.8 | 76% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | GRDN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 21.6% | 27.8% | 23% |
|
| Net Margin | 4.5% | 1.2% | 46% |
|
| ROA | 16.5% | 2.2% | 94% |
|
| ROE | 31.7% | 7.2% | 88% |
|
| Liabilities to Assets | 41.9% | 58.6% | 33% |
|
| F-Score | 7 | 5 | 82% |
|
Guardian Pharmacy Services, Inc. did not pass any screens on 8/20/2026.
